Homology Of Medicine & Food Series was Cimg’s largest segment in fiscal 2025, bringing in $6.35M of $10.30M (62%).
| Segment | FY 2024 | FY 2025 |
|---|---|---|
| Homology Of Medicine & Food Series | — | $6.35M |
| Computing Power Product Series | — | $3.80M |
| Maca Product Series | $1.93M | — |
| Maca Product | — | $144.73K |
| Adjustments & Eliminations | — | -$891 |
| Total | $1.93M | $10.30M |
Cimg brought in $10.30M from its four segments in fiscal 2025, the year ended September 30, 2025. Cimg regrouped these segments after fiscal 2024, so the total does not compare directly with that year's $1.93M. Homology Of Medicine & Food Series was the largest at $6.35M (61.7%), ahead of Computing Power Product Series at $3.80M (36.9%) and Maca Product at $144.73K (1.4%).
Cimg began breaking out Homology Of Medicine & Food Series in fiscal 2025, Computing Power Product Series in fiscal 2025, Maca Product in fiscal 2025 and Adjustments & Eliminations in fiscal 2025. Cimg stopped reporting Maca Product Series as a separate segment after fiscal 2024, when it brought in $1.93M. The total is net of Adjustments & Eliminations, which took $891 off revenue in fiscal 2025.
Product was Cimg’s largest product and service line in fiscal 2025, bringing in $10.23M of $10.30M (99%).
| Product and Service | FY 2024 | FY 2025 |
|---|---|---|
| Product | $1.93M | $10.23M |
| Service | — | $65.99K |
| Total | $1.93M | $10.30M |
Cimg brought in $10.30M from its two product and service lines in fiscal 2025, the year ended September 30, 2025. Cimg regrouped these lines after fiscal 2024, so the total does not compare directly with that year's $1.93M. Product was the largest at $10.23M (99.4%), ahead of Service at $65.99K (0.6%).
Cimg began breaking out Service in fiscal 2025, when it brought in $65.99K.
Cimg (CIMG) reports its revenue by segment and by product and service. In fiscal 2025, Homology Of Medicine & Food Series was its largest segment, bringing in $6.35M (61.7% of the total), followed by Computing Power Product Series at $3.80M (36.9%).
Homology Of Medicine & Food Series was Cimg's largest segment in fiscal 2025, bringing in $6.35M, or 61.7% of the $10.30M total across its four segments.
Product was Cimg's largest product and service line in fiscal 2025, bringing in $10.23M, or 99.4% of the $10.30M total across its two product and service lines.
Every figure comes from Cimg's annual financial filings, as reported. Each line keeps the name Cimg gives it, and years follow its fiscal calendar.
Cimg's revenue by segment goes back to fiscal 2024, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.